Patents by Inventor Gerard Maurer

Gerard Maurer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTIVE RENAL SAFETY BIOMARKERS AND BIOMARKER SIGNATURES TO MONITOR KIDNEY FUNCTION
    Publication number: 20140171335
    Abstract: Biomarker signatures were identified which can be used to diagnose or predict kidney or liver toxicity and more specifically renal tubular toxicity as a consequence of disease or drug treatment.
    Type: Application
    Filed: November 27, 2013
    Publication date: June 19, 2014
    Applicant: NOVARTIS AG
    Inventors: Gerard MAURER, Frank DIETERLE, Elias PERENTES, Frank STAEDTLER, Andre CORDIER, Andreas MAHL, Jacky VONDERSCHER, Daniel WAHL, Olivier GRENET, Daniel Robert ROTH
  • Use of ?-2-microglobulin to assess glomerular alterations and damage in the kidney
    Patent number: 8609812
    Abstract: The present invention is directed, in part, to a method of measuring ?-2-microglobulin to assess glomerular alteration or damage of the kidney.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: December 17, 2013
    Assignee: Novartis AG
    Inventors: Gerard Maurer, Frank Dieterle, Elias Perentes, Frank Städtler, André Cordier, Andreas Mahl, Jacky Vonderscher, Daniel Wahl, Olivier Grenet, Daniel Robert Roth
  • PREDICTIVE RENAL SAFETY BIOMARKERS AND BIOMARKER SIGNATURES TO MONITOR KIDNEY FUNCTION
    Publication number: 20100143956
    Abstract: Biomarker signatures were identified which can be used to diagnose or predict kidney or liver toxicity and more specifically renal tubular toxicity as a consequence of disease or drug treatment.
    Type: Application
    Filed: March 25, 2008
    Publication date: June 10, 2010
    Inventors: Gerard Maurer, Frank Dieterle, Elias Perentes, Frank Stadtler, Andre Cordier, Andreas Mahl, Jacky Vonderscher, Daniel Wahl, Olivier Grenet, Daniel R. Roth
  • Ergot peptide alkaloids
    Patent number: 4251529
    Abstract: Compounds of formula I ##STR1## wherein R.sub.1 is alkyl of 1 to 4 carbon atoms or benzyl,R.sub.2 is alkyl of 1 to 4 carbon atoms, andeither(i) A is .CH.sub.2.CH.sub.2.COOH; .CH.sub.2.CH(OH).COOH or .CH(OH).CH.sub.2.COOH and B is hydrogen, or (ii) A and B together are .CH.sub.2.CH(OH).CH.sub.2.; CH.sub.2.CH.sub.2.CH(OH); .CH.sub.2.CH(OH).CH(OH). or .CH(OH).CH.sub.2.CH(OH). are useful cerebral insufficiency agents.
    Type: Grant
    Filed: February 8, 1980
    Date of Patent: February 17, 1981
    Assignee: Sandoz Ltd.
    Inventors: Gerard Maurer, Jean-Rene Kiechel